A new study reveals a novel connection between aging of visceral adipose tissue and brain health. These findings are ...

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

NXP800 Phase 1b study in patients with platinum resistant, ARID1a-mutated ovarian cancer is ongoing; Orphan Drug Designation ...

CereVasc today announced the first patient randomized to and treated with the eShunt system in its STRIDE clinical trial.

Ron Bentsur, CEO commented, “In 2024, Nuvectis made important progress in the development of our two clinical-stage drug candidates, NXP800 and ...

The National Institute of Health and Care Excellence (NICE) has recommended pharmaand’s (pharma&) Rubraca (rucaparib) as a ...

The Philippine Health Insurance Corporation in Region XI (PhilHealth-Davao) disbursed P928 million to valid member claims from December 27, 2024 to January 31, 2025. A top PhilHealth official in Davao ...

Dania Daye, MD, PhD Associate Professor of Radiology, Harvard Medical School IR Division Quality Director Co-Director of IR ...